Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/32258
Title: Lower airway inflammation in infants with cystic fibrosis detected by newborn screening.
Authors: Nixon G.M. ;Grimwood K.;Jamsen K.M.;Carzino R.;Robertson C.F.;Carlin J.B.;Armstrong D.S.;Hook S.M.
Monash Health Department(s): Paediatric - Respiratory and Sleep (Melbourne Children's Sleep Centre)
Institution: (Armstrong) Department of Paediatrics, Monash Medical Centre, Monash University, Clayton, Vic., Australia (Hook) Malaghan Institute of Medical Research, Wellington, New Zealand (Jamsen, Carlin) Clinical Epidemiology and Biostatistics Unit, Murdoch Children's Research Institute, Parkville, Vic., Australia (Nixon, Carzino, Robertson) Department of Respiratory and Sleep Medicine, Royal Children's Hospital, Parkville, Vic., Australia (Grimwood) Department of Paediatrics and Child Health, Wellington School of Medicine and Health Sciences, University of Otago, Wellington, New Zealand (Grimwood) Department of Paediatrics and Child Health, Wellington School of Medicine and Health Sciences, PO Box 7343, Wellington, New Zealand
Issue Date: 18-Oct-2012
Copyright year: 2005
Publisher: Wiley-Liss Inc. (111 River Street, Hoboken NJ 07030-5774, United States)
Place of publication: United States
Publication information: Pediatric Pulmonology. 40 (6) (pp 500-510), 2005. Date of Publication: December 2005.
Abstract: Controversy exists over whether the lower airway inflammation that characterizes cystic fibrosis (CF) is initiated primarily by the genetic defect. To determine if inflammation precedes infection, we examined bronchoalveolar lavage (BAL) fluid cytology, cytokines (interleukin (IL)-1beta, IL-4, IL-5, IL-6, IL-8, IL-10, and tumor necrosis factor-alpha), and free neutrophil elastase activity from 70 CF (aged 1.5-71 months) children detected by newborn screening and 19 (aged 2.0-48 months) controls with chronic stridor. CF subjects were selected and categorized as pristine (13 aged <=6 months, lacking prior respiratory symptoms and exposure to antibiotics, and without respiratory pathogens on BAL), infected (42 with viruses or >=105 colony-forming units/ml of pathogenic bacteria in BAL), and uninfected (15 aged >=6 months, asymptomatic, not taking antibiotics at bronchoscopy, and free of pathogens in their BAL). To further resolve if inflammation develops without infection, inflammatory mediators in paired annual BAL samples from 38 CF subjects were measured, and results were grouped according to whether BAL showed persistence (n = 6), acquisition (n = 8), clearance (n = 13), or absence (n = 11) of infection. While pristine, uninfected, and control subjects had similar BAL profiles, infected patients showed elevated inflammatory indices, including increased IL-10 (P < 0.001). Pristine subjects had the fewest signs of inflammation. Analysis of BAL pairs found differences between the four infection groups for changes in neutrophil percentages, IL-8 (P < 0.001), and free neutrophil elastase (P = 0.009). Infection was associated with elevated inflammatory mediators in BAL fluid. In contrast, minimal or reduced signs of inflammation accompanied absence of eradication of infection from BAL fluid. We conclude that in CF, infection initiates and sustains airway inflammation. © 2005 Wiley-Liss, Inc.
DOI: http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1002/ppul.20294
PubMed URL: 16208679 [http://www.ncbi.nlm.nih.gov/pubmed/?term=16208679]
ISSN: 8755-6863
URI: https://repository.monashhealth.org/monashhealthjspui/handle/1/32258
Type: Article
Subjects: *lung disease/dt [Drug Therapy]
*lung disease/et [Etiology]
lung lavage
major clinical study
newborn
newborn disease/di [Diagnosis]
newborn screening
priority journal
antibiotic agent/dt [Drug Therapy]
cytokine/ec [Endogenous Compound]
elastase/ec [Endogenous Compound]
interleukin 10/ec [Endogenous Compound]
interleukin 1beta/ec [Endogenous Compound]
interleukin 4/ec [Endogenous Compound]
interleukin 5/ec [Endogenous Compound]
interleukin 6/ec [Endogenous Compound]
interleukin 8/ec [Endogenous Compound]
tumor necrosis factor alpha/ec [Endogenous Compound]
lower respiratory tract infection/dt [Drug Therapy]
airway
article
controlled study
*cystic fibrosis/di [Diagnosis]
cytokine production
enzyme assay
enzyme linked immunosorbent assay
female
Gram negative bacterium
Gram positive bacterium
human
infant
inflammation
longitudinal study
lower respiratory tract infection/co [Complication]
lower respiratory tract infection/di [Diagnosis]
male
lower respiratory tract infection/et [Etiology]
*lung disease/co [Complication]
*lung disease/di [Diagnosis]
infant
inflammation
longitudinal study
lower respiratory tract infection / complication / diagnosis / drug therapy / etiology
*lung disease / *complication / *diagnosis / *drug therapy / *etiology
lung lavage
major clinical study
male
newborn
controlled study
newborn screening
priority journal
article
airway
newborn disease / diagnosis
*cystic fibrosis / *diagnosis
cytokine production
enzyme assay
enzyme linked immunosorbent assay
female
Gram negative bacterium
Gram positive bacterium
human
Appears in Collections:Articles

Show full item record

Page view(s)

20
checked on Sep 2, 2024

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.